Question and Answer Session with Archan Ganguly, Ph.D.
In the dynamic and collaborative environment at the University of Rochester, neuroscientist Dr. Archan Ganguly has found a stimulating research hub for his work on the molecular mechanisms of synaptic protein trafficking. After completing his PhD in Neuroscience at Ohio University and his postdoctoral training at the University of California, San Diego, Dr. Ganguly joined the University of Rochester Medical Center due to his wife's recruitment to the Wilmot Cancer Institute.
Dr. Ganguly's research focuses on understanding how proteins essential for synaptic communication between neurons are trafficked. This research has particular relevance to functions such as learning, memory, and social communication. The specialized structures called synapses, where hundreds of proteins work synchronously to facilitate neuronal communication, are the focus of his studies.
One key aspect of Dr. Ganguly's research involves the transport and retention of synaptic proteins. Synaptic proteins like AMPA-type glutamate receptors (AMPARs) are synthesized in the neuronal cell body and trafficked to the synapse via complex intracellular transport mechanisms. Proteins such as PSD-95 and stargazin directly interact to control the delivery and retention of AMPARs at synapses, acting as "slots" that regulate the number of receptors incorporated into the postsynaptic membrane. Phosphorylation events and dynamic protein-protein interactions govern the synaptic insertion and stabilization of these receptors, influencing synaptic strength and plasticity.
Another important aspect of Dr. Ganguly's research is synaptic vesicle trafficking and neurotransmitter release. This regulated trafficking supports synaptic homeostasis and plasticity, adjusting synaptic function in response to neuronal activity. Proteins such as synapsins mediate recognition events that deliver vesicles carrying neurotransmitters and synaptic proteins to active zones. Regulation of protein interactions and phosphorylation, for instance by kinases such as Ca2+/calmodulin-dependent protein kinase II and cAMP-dependent protein kinase, modulates vesicle trafficking and neurotransmitter release.
The disruptions in these trafficking pathways contribute to the pathophysiology of various neurodevelopmental and neurodegenerative disorders. For example, impaired trafficking or altered phosphorylation of AMPAR subunits can compromise synaptic plasticity, leading to cognitive deficits observed in disorders such as autism spectrum disorder (a neurodevelopmental condition) or Alzheimer's disease (a neurodegenerative disease). Alterations in synaptic vesicle trafficking proteins and their signaling cascades are similarly implicated in disease mechanisms affecting synaptic transmission and neuronal health.
While direct publications from Dr. Ganguly were not identified in the search results, his research likely involves elucidating how molecular defects in these trafficking processes lead to synaptic dysfunction in disease models at the University of Rochester Medical Center. Dr. Ganguly collaborates with Dr. Christoph Proschelin, Department of Biomedical Genetics, and Dr. Krishnan Padmanabhan, Neuroscience, in his research endeavors.
Dr. Ganguly finds the fun in science to be in doing the hardest experiments and persevering through failures, learning from every mistake. His favorite piece of advice comes from Bob Dylan's song 'Love Minus Zero/No Limit': "There is no success like failure and failure is no success at all." This philosophy drives Dr. Ganguly's passion for uncovering the mysteries of synaptic protein trafficking and its implications for neurodevelopmental and neurodegenerative disorders.
For those interested in detailed data from Dr. Ganguly’s own publications, I recommend checking his lab’s profiles or scientific databases directly from the University of Rochester Medical Center resources.
Science plays a substantial role in Dr. Ganguly's work, as he explores the molecular mechanisms of synaptic protein trafficking, particularly in relation to medical-conditions such as learning, memory, and social communication. His research also focuses on understanding the impact of these mechanisms on health-and-wellness, with findings relevant to neurodevelopmental and neurodegenerative disorders.
